1. Usmani, Muhammad A, Ahmed, Zubair M, Magini, Pamela, Riazuddin, Sheikh, Riazuddin, Saima. 2021. De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy. In American journal of human genetics, 108, 1330-1341. doi:10.1016/j.ajhg.2021.05.007. https://pubmed.ncbi.nlm.nih.gov/34102099/
2. Rebendenne, Antoine, Roy, Priyanka, Bonaventure, Boris, Doench, John G, Goujon, Caroline. 2022. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs. In Nature genetics, 54, 1090-1102. doi:10.1038/s41588-022-01110-2. https://pubmed.ncbi.nlm.nih.gov/35879413/
3. Johnson, Kenneth R, Gagnon, Leona H, Chang, Bo. 2016. A hypomorphic mutation of the gamma-1 adaptin gene (Ap1g1) causes inner ear, retina, thyroid, and testes abnormalities in mice. In Mammalian genome : official journal of the International Mammalian Genome Society, 27, 200-12. doi:10.1007/s00335-016-9632-0. https://pubmed.ncbi.nlm.nih.gov/27090238/
4. Dong, Yanfen, Yang, He, Hua, Handan. 2022. MicroRNA-641 Inhibits Endometrial Cancer Progression via Targeting AP1G1. In Evidence-based complementary and alternative medicine : eCAM, 2022, 7918596. doi:10.1155/2022/7918596. https://pubmed.ncbi.nlm.nih.gov/36212964/
5. Yun, W-K, Hu, Y-M, Zhao, C-B, Yu, D-Y, Tang, J-B. . HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway. In European review for medical and pharmacological sciences, 23, 2786-2793. doi:10.26355/eurrev_201904_17553. https://pubmed.ncbi.nlm.nih.gov/31002129/
6. Sun, Y, Cao, F-L, Qu, L-L, Wang, Z-M, Liu, X-Y. . MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1. In European review for medical and pharmacological sciences, 23, 1459-1467. doi:10.26355/eurrev_201902_17103. https://pubmed.ncbi.nlm.nih.gov/30840267/